Manhattan Associates Valuation
Is MANH * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
1/6Valuation Score 1/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of MANH * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: MANH * (MX$4053.48) is trading above our estimate of fair value (MX$2829.3)
Significantly Below Fair Value: MANH * is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for MANH *?
Other financial metrics that can be useful for relative valuation.
What is MANH *'s n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | US$14.20b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 14.6x |
Enterprise Value/EBITDA | 62.1x |
PEG Ratio | 5.8x |
Price to Earnings Ratio vs Peers
How does MANH *'s PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 88.8x | ||
NICE NICE | 33.7x | 14.1% | ₪45.6b |
DOCU DocuSign | 167.4x | 27.8% | US$12.3b |
DT Dynatrace | 92.9x | 18.8% | US$14.3b |
NEM Nemetschek | 61.2x | 16.1% | €10.3b |
MANH * Manhattan Associates | 74.1x | 12.7% | Mex$14.2b |
Price-To-Earnings vs Peers: MANH * is good value based on its Price-To-Earnings Ratio (74.1x) compared to the peer average (88.8x).
Price to Earnings Ratio vs Industry
How does MANH *'s PE Ratio compare vs other companies in the Global Software Industry?
Price-To-Earnings vs Industry: MANH * is expensive based on its Price-To-Earnings Ratio (74.1x) compared to the Global Software industry average (33.1x).
Price to Earnings Ratio vs Fair Ratio
What is MANH *'s PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 74.1x |
Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate MANH *'s Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.